温肺止咳颗粒对哮喘患者肺功能及FeNO的影响
2020-12-23侯海慧唐艳芬朱慧苏成程
侯海慧 唐艳芬 朱慧 苏成程


摘要:目的 观察温肺止咳颗粒联合西药对哮喘患者肺功能及FeNO的影响。方法 将60例哮喘患者随机分为对照组30例与治疗组30例。对照组予布地奈德福莫特罗吸入剂及茶碱药物控制,治疗组在对照组基础上加用温肺止咳颗粒,疗程10 d。比较2组治疗前后肺功能及呼出气NO指标。结果 治疗组FEV1(2.51±0.86)L、FEV1%(72.83±9.75)%、FVC(3.52±0.79)L、呼出气NO(35.93±14.05)ppb,对照组FEV1(1.94±0.90)L、FEV1%(82.46±9.14)%、FVC(3.17±0.68)L、呼出气NO(45.13±14.98)ppb,2组数据比较,均有显著差[JP3]异(P<0.05)。结论 温肺止咳颗粒联合西药治疗哮喘患者能显著改善患者的肺功能,降低气道高反应,疗效较好。
关键词:温肺止咳颗粒;支气管哮喘;冷哮;肺功能;呼出气NO
中图分类号:R256.12 文献标志码:B 文章编号:1007-2349(2020)11-0037-03
【Abstract】Objective: To observe the effects of Wenfei Zhike Granules combined with western medicine on lung function and FeNO in asthmatic patients. Methods: 60 asthma patients were randomly divided into a control group and a treatment group, 30 cases per group. The control group was treated with budesonide formoterol inhalation and theophylline drugs, and the treatment group was added Wenfei Zhike granules on the basis treatment of the control group. Ten days was a course of treatment. The lung functions and exhaled NO indexes before and after treatment were compared between the two groups. Results: The treatment got FEV1(2.51±0.86)L, FEV1% (72.83±9.75)%, FVC(3.52±0.79)L, exhaled NO(35.93±14.05) ppb and the control group got FEV1(1.94±0.90)L, FEV1 in the control group %(82.46±9.14)%, FVC (3.17±0.68)L, exhaled NO (45.13±14.98) ppb. There was a significant difference between the data of the two groups (P<0.05). Conclusion: The combination of Wenfeizhike Granules and western medicine in the treatment of asthma patients can significantly improve the lung function of the patients and reduce the airway hyperresponsiveness of the patients, and has a better effect.
【Key words】Wenfei Zhike Granules, bronchial asthma, cold asthma, lung function, exhaled NO
據世界卫生组织统计,世界上患有支气管哮喘疾病的患者达3亿人,至2025年,患病人数会增加至4亿。通过对2009年至2011我国不同地区发病率的统计,我国的发病率高达1.25%,且发病率呈上升趋势。[1]
支气管哮喘是由多种细胞及细胞组分参与的慢性气道炎症,表现为气道反应性增高、气流受限。临床症状见反复发作的喘息、气促、胸闷和(或)咳嗽等症状。不同国家对其诊断标准定义有所区别,“金标准”有症状及体征、支气管舒张试验、支气管激发试验及PEF检测等,日本、印度及西班牙的标准中加入了呼出气NO(Fractional exhaled nitric oxide,FeNO)。[2]有研究显示FeNO对支气管哮喘的诊断阳性率与肺功能相近,两者联合检测可提高诊断的灵敏度[3]。
本次试验通过观察患者治疗前后的肺功能及FeNO的变化评价温肺止咳颗粒联合西药治疗的疗效,现报道如下。
1 资料与方法
1.1 一般资料 选取自2017年2月—2018年10月在南通市中医院进行治疗的60例冷哮患者,均符合哮喘诊断标准[4]及冷哮诊断标准[5],症见:喉中哮鸣有声,胸膈满闷,咳痰稀白,面色晦滞。……
